Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing ...
The UK government has confirmed £55 billion of long-term R&D funding for the UK’s research agencies and bodies in an effort to create jobs, boost the economy and deliver science and tech breakthroughs ...